← Back to summaries

INCY

Incyte Corp
Healthcare · Biotechnology · Data as of 2026-03-20
$91.17
SMA 20
SMA 50
SMA 200

📊 Valuation

Forward P/E10.2
Trailing P/E14.2
PEG Ratio0.84
Market Cap18.14B
Target Price$109.33

📈 Technicals

Trenddowntrend
RSI (14)34
Rel. Strength Rank42%
Above 50 SMA❌
Above 200 SMA✅

💰 Fundamentals

EPS (TTM)6.40
ROE29.87%
Profit Margin25.03%
Dividend-

🎯 Strategy Analysis

Value Momentum 75 - PASS
  • Eligible asset class.
  • Intermediate trend does not confirm.
  • Liquidity clears threshold.
  • Price is above the 200 SMA.
  • Relative strength is weak.
price-action 70 - WATCH
  • Eligible asset class for price action.
  • Clear market structure present.
  • Price at supply/demand zone.
  • No liquidity sweep detected.
  • Volume not confirming.
Bounce / Swing 52 - FAIL
  • Eligible equity for bounce/swing.
  • Trend context does not support bounce setup.
  • Pullback/consolidation pattern exists.
  • Support and resistance are defined.
  • Liquidity clears swing-trade threshold.
iron-condor 50 - FAIL
  • Eligible asset class for iron condor.
  • Live option-chain inputs unavailable.
  • Stock is trending - iron condor less ideal.
  • No earnings within DTE window.
  • Support and resistance levels defined for wing placement.
Covered Call / CSP 48 - FAIL
  • Eligible equity underlying.
  • No listed options available.
  • Underlying/options liquidity is acceptable.
  • Underlying is acceptable to own on assignment.
  • Support/resistance anchors exist for strike selection.